Cosmetics · Quasi-drug actives

5,5'-Dipropyl-Biphenyl-2,2'-Diol

5,5'-ジプロピル-ビフェニル-2,2'-ジオール (Dipuropiru bifenīru jiōru)

Also known as: Kao (formerly Kanebo) markets a preparation as Magnolignan

At a glance

CategoryCosmetics
INCI nameMagnolignan / Dipropyl Biphenyl Diol (specification-dependent)
Japanese labeling name5,5'-ジプロピル-ビフェニル-2,2'-ジオール
Common Japanese notations5,5'-ジプロピル-ビフェニル-2,2'-ジオール
OriginSynthetic (biphenyl derivative)
Typical functionsQuasi-drug whitening (medicated bihaku) active
Regulatory status in JapanApproved as a quasi-drug (医薬部外品) whitening active by Japan's MHLW in 2005. Approval applied for by Kanebo Cosmetics.

5,5'-Dipropyl-biphenyl-2,2'-diol is a synthetic biphenyl derivative approved as a quasi-drug whitening active in Japan in 2005. Kanebo Cosmetics — now part of Kao Corporation — applied for and received the approval, and markets its preparation of this ingredient under the brand name Magnolignan.

Classification

Tags below link to other ingredients sharing the same attribute, so you can pivot from one ingredient to its peers.

Used in (typical product categories)

Finished-product categories that commonly include this ingredient in Japanese-market formulations.

  • Medicated whitening lines (薬用美白) marketed under Kao / Kanebo brands

What it is

5,5'-Dipropyl-biphenyl-2,2'-diol is a substituted biphenyl with hydroxyl groups at the 2 and 2' positions and propyl substituents at the 5 and 5' positions. It functions through the melanin synthesis pathway as a quasi-drug whitening active.

Typical uses in Japanese products

Use is concentrated in Kao / Kanebo medicated whitening lines.

Regulatory classification in Japan

Approved by MHLW as a quasi-drug whitening active in 2005 following Kanebo Cosmetics' application.

Regulatory classification in other markets

EUVerify specific INCI registration in current CosIng.
USAVerify INCI registration.
ChinaVerify against current IECIC listings.
KoreaVerify against current KFDA / MFDS listings.

Example products

Use is concentrated in Kao / Kanebo medicated whitening lines. Specific SKU listings will be added after each product's current full ingredient list has been verified.

All brand names and product names referenced anywhere on this site are the property of their respective owners. Example entries are provided for informational purposes only and do not imply endorsement.

Related ingredients

References

  1. Japan PMDA — quasi-drug active ingredient approval registry
  2. Kao Corporation / Kanebo Cosmetics technical publications referencing Magnolignan

Last updated: 2026-04-22. Ingredient entries are reviewed at least annually against current regulatory listings.

Explore more Japan-market resources

Related tools for overseas buyers, formulators, and sourcing teams.